Coherus Oncology Inc
(CHRS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 89,833 | -209,409 | -238,286 | -127,788 | -223,938 |
| Depreciation Amortization | 3,259 | 3,235 | 3,398 | 2,996 | 1,869 |
| Accounts receivable | -141,992 | N/A | 1,859 | -299 | 2,710 |
| Accounts payable and accrued liabilities | 9,893 | -534 | -4,454 | -7,636 | 19,932 |
| Other Working Capital | -112,534 | 10,297 | -5,133 | -159,214 | 91,115 |
| Other Operating Activity | 179,896 | 37,145 | 42,330 | 39,396 | 322 |
| Operating Cash Flow | $28,355 | $-159,266 | $-200,286 | $-252,545 | $-107,990 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,822 | -789 | -4,573 | -6,515 | -6,164 |
| Purchase Of Investment | -20,235 | -42,869 | -74,344 | N/A | N/A |
| Sale Of Investment | 20,400 | 43,170 | 74,500 | N/A | N/A |
| Other Investing Activity | -11,075 | -700 | 0 | 0 | -785 |
| Investing Cash Flow | $-12,732 | $-1,188 | $-4,417 | $-6,515 | $-6,949 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 100,000 | N/A |
| Common Stock Issued | 13,711 | 103,830 | 482 | 126,918 | 1,429 |
| Common Stock Repurchased | 3,519 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 72,140 | 1,591 | 206,305 | -739 | 121,260 |
| Financing Cash Flow | $89,370 | $105,421 | $206,787 | $226,179 | $122,689 |
| Exchange Rate Effect | -276 | 468 | -120 | -398 | 84 |
| Beginning Cash Position | 73,191 | 127,756 | 125,792 | 159,071 | 150,392 |
| End Cash Position | 177,908 | 73,191 | 127,756 | 125,792 | 158,226 |
| Net Cash Flow | $104,717 | $-54,565 | $1,964 | $-33,279 | $7,834 |
| Free Cash Flow | |||||
| Operating Cash Flow | 28,355 | -159,266 | -200,286 | -252,545 | -107,990 |
| Capital Expenditure | -1,822 | -789 | -4,573 | -6,515 | -6,164 |
| Free Cash Flow | 26,533 | -160,055 | -204,859 | -259,060 | -114,154 |